Invention Grant
- Patent Title: Chromen-4-one derivatives for the treatment and prophylaxis of hepatitis B virus disease
-
Application No.: US17285785Application Date: 2019-10-17
-
Publication No.: US11993591B2Publication Date: 2024-05-28
- Inventor: Song Feng , Chungen Liang , Yongfu Liu , Xuefei Tan , Jun Wu , Jianping Wang
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Priority: WO TCN2018111037 2018.10.19
- International Application: PCT/EP2019/078131 2019.10.17
- International Announcement: WO2020/079106A 2020.04.23
- Date entered country: 2021-04-15
- Main IPC: C07D405/12
- IPC: C07D405/12 ; A61P31/20 ; C07D311/22 ; C07D311/24 ; C07D405/04 ; C07D405/06 ; C07D417/12 ; C07D451/06 ; C07D487/10
Abstract:
The present invention provides novel compounds having the general formula (I) wherein R1 to R6, and m are as described herein, compositions including the compounds and methods of using the compounds.
Public/Granted literature
- US20220402897A1 CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE Public/Granted day:2022-12-22
Information query
